Newly elected members of the AACR Board of Directors and AACR Nominating Committee

The AACR Board of Directors and Nominating Committee consist of world-renowned leaders in the field of cancer research. The following five cancer researchers have been elected to the Board of Directors for the 2022–2025 term:


John D. Carpten, PhD, FAACR, is professor and chair for the Department of Translational Genomics, and is the Royce and Mary Trotter Chair in Cancer Research, Keck School of Medicine, University of Southern California (USC). He also serves as associate director of basic sciences for the USC Norris Comprehensive Cancer Center.

Christina Curtis, PhD, is associate professor of medicine and genetics and an Endowed Scholar at Stanford University School of Medicine; director of Breast Cancer Translational Research and codirector of the Molecular Tumor Board at the Stanford Cancer Institute; and a Chan Zuckerberg Biohub Investigator at Stanford.

William Pao, MD, PhD, is chief development officer and executive vice president at Pfizer.

Kimberly Stegmaier, MD, is professor of pediatrics at Harvard Medical School; Ted Williams Investigator at Dana-Farber Cancer Institute (DFCI); vice chair for pediatric oncology research, codirector of the Pediatric Hematologic Malignancy Program, and pediatric oncologist at DFCI and Boston Children’s Hospital; and an Institute Member of the Broad Institute, Massachusetts Institute of Technology.

Robert H. Vonderheide, MD, DPhil, is director of the Abramson Cancer Center and vice dean and vice president of cancer programs for the Perelman School of Medicine and the University of Pennsylvania Health System.

In addition, the following four scientists were elected to the Nominating Committee:

Susan M. Domchek, MD, is executive director, Basser Center for BRCA, and Basser Professor in Oncology, Abramson Cancer Center, University of Pennsylvania.

Elaine R. Mardis, PhD, FAACR, is co-executive director of The Steve and Cindy Rasmussen Institute for Genomic Medicine and The Steve and Cindy Rasmussen Nationwide Foundation endowed chair in genomic medicine at Nationwide Children’s Hospital; and professor of pediatrics, The Ohio State University College of Medicine. She served as AACR President in 2019-2020.

Antoni Ribas, MD, PhD, FAACR, is professor of medicine, surgery, and molecular and medical pharmacology; director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center; and director of the Parker Institute for Cancer Immunotherapy Center at the University of California, Los Angeles (UCLA). He served as AACR President in 2020-2021.

Sheila A. Stewart, PhD, is vice chair and Gerty T. Cori Professor, Department of Cell Biology and Physiology and professor, Department of Internal Medicine, Division of Molecular Oncology, Washington University School of Medicine; codirector, Molecular and Cellular Biology Program, and associate director for basic science, The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Back to HCB News

More People on the Move